Medicine@Brown
Could an HIV Drug Slow Human Aging?
Researchers at Brown and the University of Rochester are testing whether an HIV drug can reduce DNA-triggered inflammation and slow the aging process.
The federal Advanced Research Projects Agency for Health (ARPA-H) is supporting the multicenter study with up to $22 million over five years. It’s led by John Sedivy, PhD, director of the Center on the Biology of Aging at Brown, and Vera Gorbunova, PhD, co-director of the Rochester Aging Research Center.
The federal Advanced Research Projects Agency for Health (ARPA-H) is supporting the multicenter study with up to $22 million over five years. It’s led by John Sedivy, PhD, director of the Center on the Biology of Aging at Brown, and Vera Gorbunova, PhD, co-director of the Rochester Aging Research Center.